Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study

Author:

Bansal Nisha1,Zelnick Leila1,Go Alan2,Anderson Amanda3,Christenson Robert4,Deo Rajat5,Defilippi Christopher6,Lash James7,He Jiang3,Ky Bonnie5,Seliger Stephen4,Soliman Elsayed8,Shlipak Michael9,Appel Lawrence J.,Feldman Harold I.,Rao Panduranga S.

Affiliation:

1. University of Washington Seattle WA

2. Division of Research Kaiser Permanente Northern California Oakland CA

3. Tulane University New Orleans LA

4. University of Maryland Baltimore MD

5. University of Pennsylvania Philadelphia PA

6. Inova Health System Falls Church VA

7. University of Illinois, Chicago IL

8. Wake Forest University Winston‐Salem NC

9. University of California, San Francisco San Francisco CA

Abstract

Background Cardiac biomarkers may signal mechanistic pathways involved in heart failure ( HF ), a leading complication in chronic kidney disease. We tested the associations of NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide), high‐sensitivity troponin T (hsTnT), galectin‐3, growth differentiation factor‐15 ( GDF ‐15), and soluble ST 2 ( sST 2) with incident HF in chronic kidney disease. Methods and Results We examined adults with chronic kidney disease enrolled in a prospective, multicenter study. All biomarkers were measured at baseline. The primary outcome was incident HF . Secondary outcomes included HF with preserved ejection fraction (EF≥50%) and reduced ejection fraction (EF<50%). Cox models were used to test the association of each cardiac biomarker with HF , adjusting for demographics, kidney function, cardiovascular risk factors, and medication use. Among 3314 participants, all biomarkers, with the exception of galectin‐3, were significantly associated with increased risk of incident HF (hazard ratio per SD higher concentration of log‐transformed biomarker): NT ‐pro BNP (hazard ratio, 2.07; 95% CI , 1.79–2.39); hsTnT (hazard ratio, 1.38; 95% CI , 1.21–1.56); GDF ‐15 (hazard ratio, 1.44; 95% CI , 1.26–1.66) and sST 2 (hazard ratio, 1.19; 95% CI, 1.05–1.35). Higher NT ‐pro BNP , hsTnT, and GDF ‐15 were also associated with a greater risk of HF with reduced EF ; while higher NT ‐pro BNP GDF ‐15 and sST 2 were associated with HF with preserved EF . Galectin‐3 was not associated with either HF with reduced EF or HF with preserved EF. Conclusions In chronic kidney disease, elevations of NT ‐pro BNP , hsTnT, GDF ‐15, sST 2 were associated with incident HF . There was a borderline association of galectin‐3 with incident HF . NT ‐pro BNP and hsTnT were more strongly associated with HF with reduced EF , while the associations of the newer biomarkers GDF ‐15 and sST 2 were stronger for HF with preserved EF.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3